Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency

D Fiorentini, C Cappadone, G Farruggia, C Prata - Nutrients, 2021 - mdpi.com
Magnesium plays an important role in many physiological functions. Habitually low intakes
of magnesium and in general the deficiency of this micronutrient induce changes in …

[HTML][HTML] Magnesium in man: implications for health and disease

JHF De Baaij, JGJ Hoenderop… - Physiological …, 2015 - journals.physiology.org
Abstract Magnesium (Mg 2+) is an essential ion to the human body, playing an instrumental
role in supporting and sustaining health and life. As the second most abundant intracellular …

Calcitonin gene-related peptide: physiology and pathophysiology

FA Russell, R King, SJ Smillie, X Kodji… - Physiological …, 2014 - journals.physiology.org
Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide. Discovered 30
years ago, it is produced as a consequence of alternative RNA processing of the calcitonin …

Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses

V Fattori, MSN Hohmann, AC Rossaneis… - Molecules, 2016 - mdpi.com
In this review, we discuss the importance of capsaicin to the current understanding of
neuronal modulation of pain and explore the mechanisms of capsaicin-induced pain. We …

Blocking CGRP in migraine patients–a review of pros and cons

M Deen, E Correnti, K Kamm, T Kelderman… - The journal of headache …, 2017 - Springer
Migraine is the most prevalent neurological disorder worldwide and it has immense
socioeconomic impact. Currently, preventative treatment options for migraine include drugs …

Calcitonin gene-related peptide (CGRP): a new target for migraine

AF Russo - Annual review of pharmacology and toxicology, 2015 - annualreviews.org
Migraine is a neurological disorder that manifests as a debilitating headache associated
with altered sensory perception. The neuropeptide calcitonin gene-related peptide (CGRP) …

Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention

RB Lipton, SD Silberstein - … : The Journal of Head and Face …, 2015 - Wiley Online Library
Migraine is a common disabling primary headache disorder that affects an estimated 36
million A mericans. Migraine headaches often occur over many years or over an individual's …

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

T Voss, RB Lipton, DW Dodick, N Dupre, JY Ge… - …, 2016 - journals.sagepub.com
Aim The aim of this trial was to evaluate the efficacy and tolerability of ubrogepant (MK-
1602), a calcitonin gene-related peptide receptor antagonist (CGRP-RA), for the acute …

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention

TW Ho, KM Connor, Y Zhang, E Pearlman… - Neurology, 2014 - AAN Enterprises
Objective: To evaluate whether the calcitonin gene-related peptide (CGRP) receptor
antagonist telcagepant might be effective for migraine prevention. Methods: In this …

Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier

S Eftekhari, CA Salvatore, S Johansson, T Chen… - Brain research, 2015 - Elsevier
Calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated anti-
migraine efficacy. One remaining question is where do these blockers act? We hypothesized …